Wells Fargo Names Top Pick in Biotechnology Sector

More in Finance

• Bought Indo Thai Securities shares in 2026? Stock crashes 90% after two years of multibagger gains; what went wrong?

  The severe downturn follows two consecutive years of outsized market gains, driven down by deteriorating corporate earnings and heavy profit booking. A swift reversal into net losses alongside steep revenue contractions has sharply eroded valuation. The resulting sell-off disproportionately impacts retail shareholders, who had recently grown their collective ownership stake in the brokerage firm.

  3 min read
• Cerebras Systems Q3 2026 earnings preview: key metrics and risks to watch

  Market participants are preparing to analyze the upcoming financial results for Cerebras Systems as the firm approaches the conclusion of its third quarter. The upcoming disclosures will offer critical visibility into the company's operational trajectory and performance metrics within the high-performance computing hardware sector. Investors will be scrutinizing the report closely to gauge operational execution against ongoing industry headwinds and potential corporate risk factors.

  1 min read
• Nebius earnings preview: what to watch when Q3 results hit Thursday

  Nebius is scheduled to release its third-quarter financial results this Thursday. The upcoming report will provide key details on the company's recent operational and financial performance.

  1 min read